Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2023

Open Access 01-12-2023 | Diabetes | Research

Smoking behavior change and risk of cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus

Authors: Su-Min Jeong, Jung Eun Yoo, Junhee Park, Wonyoung Jung, Kyu Na Lee, Kyungdo Han, Cheol Min Lee, Ki-Woong Nam, Seung-Pyo Lee, Dong Wook Shin

Published in: Cardiovascular Diabetology | Issue 1/2023

Login to get access

Abstract

Background

We aimed to examine the association between smoking behavior change and risk of cardiovascular disease (CVD) incidence and mortality in patients with type 2 diabetes mellitus (T2DM).

Methods

This study used nationwide data from the Korean National Health Insurance System and included 349,137 T2DM patients who smoked. Smoking behavior changes were defined with five groups: quitters, reducers I (≥ 50% reduction), reducers II (20–50% reduction), sustainers (± 20%), and increasers (≥ 20% increase) from the number of cigarettes/day at the baseline.

Results

During a median follow-up of 5.1 years, 6,514 cases of myocardial infarction (MI) (1.9%), 7,837 cases of ischemic stroke (IS) (2.2%), and 14,932 deaths (4.3%) were identified. Quitters had a significantly decreased risk of MI (adjusted hazard ratio [aHR] 0.80, 95% CI 0.75–0.86) and IS (aHR 0.80, 95% CI 0.75–0.85) compared to sustainers, whereas reducers did not have a significant association with the risk of MI (aHR 1.03, 95% CI 0.94–1.13) and IS (aHR 1.00, 95% CI 0.92–1.08) in reducer I. Quitters also had a lower all-cause and CVD mortality than sustainers.

Conclusions

Smoking cessation was associated with decreased CVD incidence, and all-cause and CVD mortality among T2DM patients. However, smoking reduction was not associated with decreased risks for these.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.CrossRefPubMed Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.CrossRefPubMed
2.
go back to reference Ling W, Huang Y, Huang Y-M, Fan R-R, Sui Y, Zhao H-L. Global trend of diabetes mortality attributed to vascular complications, 2000–2016. Cardiovasc Diabetol. 2020;19(1):182.CrossRefPubMed Ling W, Huang Y, Huang Y-M, Fan R-R, Sui Y, Zhao H-L. Global trend of diabetes mortality attributed to vascular complications, 2000–2016. Cardiovasc Diabetol. 2020;19(1):182.CrossRefPubMed
3.
go back to reference Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010. 6, Cardiovascular Diseases. Available from: https://www.ncbi.nlm.nih.gov/books/NBK53012/. Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010. 6, Cardiovascular Diseases. Available from: https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK53012/​.
4.
go back to reference Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.CrossRefPubMed Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.CrossRefPubMed
5.
go back to reference Pan A, Wang Y, Talaei M, Hu FB. Relation of Smoking with Total Mortality and Cardiovascular events among patients with diabetes Mellitus. Circulation. 2015;132(19):1795–804.CrossRefPubMed Pan A, Wang Y, Talaei M, Hu FB. Relation of Smoking with Total Mortality and Cardiovascular events among patients with diabetes Mellitus. Circulation. 2015;132(19):1795–804.CrossRefPubMed
6.
go back to reference Chuahirun T, Simoni J, Hudson C, Seipel T, Khanna A, Harrist RB, Wesson DE. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci. 2004;327(2):57–67.CrossRefPubMed Chuahirun T, Simoni J, Hudson C, Seipel T, Khanna A, Harrist RB, Wesson DE. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci. 2004;327(2):57–67.CrossRefPubMed
7.
go back to reference Campagna D, Alamo A, Di Pino A, Russo C, Calogero AE, Purrello F, Polosa R. Smoking and diabetes: dangerous liaisons and confusing relationships. Diabetol Metab Syndr. 2019;11(1):85.CrossRefPubMed Campagna D, Alamo A, Di Pino A, Russo C, Calogero AE, Purrello F, Polosa R. Smoking and diabetes: dangerous liaisons and confusing relationships. Diabetol Metab Syndr. 2019;11(1):85.CrossRefPubMed
8.
go back to reference Yang Y, Peng N, Chen G, Wan Q, Yan L, Wang G, Qin Y, Luo Z, Tang X, Huo Y, et al. Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events. Cardiovasc Diabetol. 2022;21(1):14.CrossRefPubMed Yang Y, Peng N, Chen G, Wan Q, Yan L, Wang G, Qin Y, Luo Z, Tang X, Huo Y, et al. Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events. Cardiovasc Diabetol. 2022;21(1):14.CrossRefPubMed
9.
go back to reference Clair C, Rigotti NA, Porneala B, Fox CS, D’Agostino RB, Pencina MJ, Meigs JB. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA. 2013;309(10):1014–21.CrossRefPubMed Clair C, Rigotti NA, Porneala B, Fox CS, D’Agostino RB, Pencina MJ, Meigs JB. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA. 2013;309(10):1014–21.CrossRefPubMed
10.
go back to reference Luo J, Rossouw J, Margolis KL. Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. JAMA. 2013;310(1):94–6.CrossRefPubMed Luo J, Rossouw J, Margolis KL. Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. JAMA. 2013;310(1):94–6.CrossRefPubMed
11.
go back to reference Liu G, Hu Y, Zong G, Pan A, Manson JE, Rexrode KM, Rimm EB, Hu FB, Sun Q. Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study. The Lancet Diabetes & Endocrinology. 2020;8(2):125–33.CrossRef Liu G, Hu Y, Zong G, Pan A, Manson JE, Rexrode KM, Rimm EB, Hu FB, Sun Q. Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study. The Lancet Diabetes & Endocrinology. 2020;8(2):125–33.CrossRef
12.
go back to reference Kim MK, Han K, Kim B, Kim J, Kwon H-S. Effects of exercise initiation and smoking cessation after new-onset type 2 diabetes mellitus on risk of mortality and cardiovascular outcomes. Sci Rep. 2022;12(1):10656.CrossRefPubMed Kim MK, Han K, Kim B, Kim J, Kwon H-S. Effects of exercise initiation and smoking cessation after new-onset type 2 diabetes mellitus on risk of mortality and cardiovascular outcomes. Sci Rep. 2022;12(1):10656.CrossRefPubMed
13.
go back to reference Cho MH, Lee K, Park SM, Chang J, Choi S, Kim K, Koo H-Y, Jun J-H, Kim SM. Effects of smoking habit change on all-cause mortality and cardiovascular diseases among patients with newly diagnosed diabetes in Korea. Sci Rep. 2018;8(1):5316.CrossRefPubMedPubMedCentral Cho MH, Lee K, Park SM, Chang J, Choi S, Kim K, Koo H-Y, Jun J-H, Kim SM. Effects of smoking habit change on all-cause mortality and cardiovascular diseases among patients with newly diagnosed diabetes in Korea. Sci Rep. 2018;8(1):5316.CrossRefPubMedPubMedCentral
14.
go back to reference Blomster JI, Woodward M, Zoungas S, Hillis GS, Harrap S, Neal B, Poulter N, Mancia G, Chalmers J, Huxley R. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (action in diabetes and vascular disease: Preterax and Diamicron modified release controlled evaluation) trial. BMJ Open. 2016;6(1):e009668.CrossRefPubMedPubMedCentral Blomster JI, Woodward M, Zoungas S, Hillis GS, Harrap S, Neal B, Poulter N, Mancia G, Chalmers J, Huxley R. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (action in diabetes and vascular disease: Preterax and Diamicron modified release controlled evaluation) trial. BMJ Open. 2016;6(1):e009668.CrossRefPubMedPubMedCentral
15.
go back to reference Choi JW, Han E, Kim TH. Association of smoking cessation after new-onset type 2 diabetes with overall and cause-specific mortality among korean men: a nationwide population-based cohort study. BMJ Open Diabetes Res Care 2020, 8(1). Choi JW, Han E, Kim TH. Association of smoking cessation after new-onset type 2 diabetes with overall and cause-specific mortality among korean men: a nationwide population-based cohort study. BMJ Open Diabetes Res Care 2020, 8(1).
17.
go back to reference Chang JT, Anic GM, Rostron BL, Tanwar M, Chang CM. Cigarette smoking reduction and Health Risks: a systematic review and Meta-analysis. Nicotine Tob Res. 2021;23(4):635–42.CrossRefPubMed Chang JT, Anic GM, Rostron BL, Tanwar M, Chang CM. Cigarette smoking reduction and Health Risks: a systematic review and Meta-analysis. Nicotine Tob Res. 2021;23(4):635–42.CrossRefPubMed
18.
go back to reference Shin DW, Cho J, Park JH, Cho B. National General Health Screening Program in Korea: history, current status, and future direction. Precis Future Med. 2022;6(1):9–31.CrossRef Shin DW, Cho J, Park JH, Cho B. National General Health Screening Program in Korea: history, current status, and future direction. Precis Future Med. 2022;6(1):9–31.CrossRef
19.
go back to reference Rhee SY, Han KD, Kwon H, Park SE, Park YG, Kim YH, Yoo SJ, Rhee EJ, Lee WY. Association between Glycemic Status and the risk of Parkinson Disease: a Nationwide Population-Based study. Diabetes Care. 2020;43(9):2169–75.CrossRefPubMedPubMedCentral Rhee SY, Han KD, Kwon H, Park SE, Park YG, Kim YH, Yoo SJ, Rhee EJ, Lee WY. Association between Glycemic Status and the risk of Parkinson Disease: a Nationwide Population-Based study. Diabetes Care. 2020;43(9):2169–75.CrossRefPubMedPubMedCentral
20.
go back to reference Jeong SM, Han K, Kim D, Rhee SY, Jang W, Shin DW. Body mass index, diabetes, and the risk of Parkinson’s disease. Mov Disord. 2020;35(2):236–44.CrossRefPubMed Jeong SM, Han K, Kim D, Rhee SY, Jang W, Shin DW. Body mass index, diabetes, and the risk of Parkinson’s disease. Mov Disord. 2020;35(2):236–44.CrossRefPubMed
21.
go back to reference Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”--screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–7.CrossRefPubMed Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”--screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–7.CrossRefPubMed
22.
go back to reference Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731–7.CrossRefPubMed Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731–7.CrossRefPubMed
23.
go back to reference Jacobs DR Jr, Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, Blackburn H. Group ftSCS: cigarette smoking and mortality risk: twenty-five–year follow-up of the Seven Countries Study. Arch Intern Med. 1999;159(7):733–40.CrossRefPubMed Jacobs DR Jr, Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, Blackburn H. Group ftSCS: cigarette smoking and mortality risk: twenty-five–year follow-up of the Seven Countries Study. Arch Intern Med. 1999;159(7):733–40.CrossRefPubMed
24.
go back to reference Suarez L, Barrett-Connor E. Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol. 1984;120(5):670–5.CrossRefPubMed Suarez L, Barrett-Connor E. Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol. 1984;120(5):670–5.CrossRefPubMed
25.
go back to reference Gambaro G, Bax G, Fusaro M, Normanno M, Manani SM, Zanella M, Dangelo A, Fedele D, Favaro S. Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. Diabetes Nutr Metab. 2001;14(6):337–42.PubMed Gambaro G, Bax G, Fusaro M, Normanno M, Manani SM, Zanella M, Dangelo A, Fedele D, Favaro S. Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. Diabetes Nutr Metab. 2001;14(6):337–42.PubMed
26.
go back to reference Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance–a potential link with the insulin resistance syndrome. J Intern Med. 1993;233(4):327–32.CrossRefPubMed Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance–a potential link with the insulin resistance syndrome. J Intern Med. 1993;233(4):327–32.CrossRefPubMed
27.
go back to reference Bergman BC, Perreault L, Hunerdosse D, Kerege A, Playdon M, Samek AM, Eckel RH. Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes. 2012;61(12):3156–66.CrossRefPubMed Bergman BC, Perreault L, Hunerdosse D, Kerege A, Playdon M, Samek AM, Eckel RH. Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes. 2012;61(12):3156–66.CrossRefPubMed
28.
go back to reference Hellerstein MK, Benowitz NL, Neese RA, Schwartz JM, Hoh R, Jacob P 3rd, Hsieh J, Faix D. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest. 1994;93(1):265–72. Hellerstein MK, Benowitz NL, Neese RA, Schwartz JM, Hoh R, Jacob P 3rd, Hsieh J, Faix D. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest. 1994;93(1):265–72.
29.
go back to reference Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. Smoking and smoking cessation in relation to mortality in women. JAMA. 2008;299(17):2037–47.CrossRefPubMed Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. Smoking and smoking cessation in relation to mortality in women. JAMA. 2008;299(17):2037–47.CrossRefPubMed
30.
go back to reference Gellert C, Schöttker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and Meta-analysis. Arch Intern Med. 2012;172(11):837–44.CrossRefPubMed Gellert C, Schöttker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and Meta-analysis. Arch Intern Med. 2012;172(11):837–44.CrossRefPubMed
31.
go back to reference Jeong S-M, Jeon KH, Shin DW, Han K, Kim D, Park SH, Cho MH, Lee CM, Nam K-W, Lee SP. Smoking cessation, but not reduction, reduces cardiovascular disease incidence. Eur Heart J. 2021;42(40):4141–53.CrossRefPubMed Jeong S-M, Jeon KH, Shin DW, Han K, Kim D, Park SH, Cho MH, Lee CM, Nam K-W, Lee SP. Smoking cessation, but not reduction, reduces cardiovascular disease incidence. Eur Heart J. 2021;42(40):4141–53.CrossRefPubMed
32.
go back to reference Godtfredsen NS, Holst C, Prescott E, Vestbo J, Osler M. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from the Copenhagen Centre for prospective Population Studies. Am J Epidemiol. 2002;156(11):994–1001.CrossRefPubMed Godtfredsen NS, Holst C, Prescott E, Vestbo J, Osler M. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from the Copenhagen Centre for prospective Population Studies. Am J Epidemiol. 2002;156(11):994–1001.CrossRefPubMed
33.
go back to reference Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC. Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation. J Am Coll Cardiol. 2002;39(11):1758–63.CrossRefPubMed Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC. Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation. J Am Coll Cardiol. 2002;39(11):1758–63.CrossRefPubMed
34.
go back to reference Hackshaw A, Morris JK, Boniface S, Tang J-L, Milenković D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018;360:j5855.CrossRefPubMed Hackshaw A, Morris JK, Boniface S, Tang J-L, Milenković D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018;360:j5855.CrossRefPubMed
35.
go back to reference de Jong M, Woodward M, Peters SAE. Duration of diabetes and the risk of major cardiovascular events in women and men: a prospective cohort study of UK Biobank participants. Diabetes Res Clin Pract. 2022;188:109899.CrossRefPubMed de Jong M, Woodward M, Peters SAE. Duration of diabetes and the risk of major cardiovascular events in women and men: a prospective cohort study of UK Biobank participants. Diabetes Res Clin Pract. 2022;188:109899.CrossRefPubMed
36.
go back to reference Salehidoost R, Mansouri A, Amini M, Aminorroaya Yamini S, Aminorroaya A. Diabetes and all-cause mortality, a 18-year follow-up study. Sci Rep. 2020;10(1):3183.CrossRefPubMedPubMedCentral Salehidoost R, Mansouri A, Amini M, Aminorroaya Yamini S, Aminorroaya A. Diabetes and all-cause mortality, a 18-year follow-up study. Sci Rep. 2020;10(1):3183.CrossRefPubMedPubMedCentral
37.
go back to reference Association AD. Standards of Medical Care in Diabetes—2022 abridged for primary care providers. Clin Diabetes. 2022;40(1):10–38.CrossRef Association AD. Standards of Medical Care in Diabetes—2022 abridged for primary care providers. Clin Diabetes. 2022;40(1):10–38.CrossRef
38.
go back to reference Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323.CrossRefPubMed Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323.CrossRefPubMed
39.
go back to reference Dimova ED, Swanson V, Evans JMM. Is diagnosis of type 2 diabetes a “teachable moment”? A qualitative study. Diabetes Res Clin Pract. 2020;164:108170.CrossRefPubMed Dimova ED, Swanson V, Evans JMM. Is diagnosis of type 2 diabetes a “teachable moment”? A qualitative study. Diabetes Res Clin Pract. 2020;164:108170.CrossRefPubMed
40.
go back to reference Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086–93.CrossRefPubMed Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086–93.CrossRefPubMed
Metadata
Title
Smoking behavior change and risk of cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus
Authors
Su-Min Jeong
Jung Eun Yoo
Junhee Park
Wonyoung Jung
Kyu Na Lee
Kyungdo Han
Cheol Min Lee
Ki-Woong Nam
Seung-Pyo Lee
Dong Wook Shin
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2023
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-01930-4

Other articles of this Issue 1/2023

Cardiovascular Diabetology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.